Skip to content
Screener

Alumis Inc. ALMS Total Operating Expenses

Total Operating Expenses at other companies

Immunome logo
ImmunomeIMNM
$59.33M+24.7%
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
$36.43M+45.2%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$57.25M-24.5%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$54.71M+15.0%
Shattuck Labs, Inc. logo
Shattuck Labs, Inc.STTK
$15.55M+8.0%

Segments

By segment

See full
Single Reportable$100.15M-15.8%

Other financials

Income statement

See full
Revenue$1.7M-90.0%
Operating income-$98.4M+3.1%
Net income-$93.1M+6.0%
EPS (diluted)-$0.74+59.3%

Balance sheet

See full
Cash & equivalents$63.9M-50.3%
Total debt$35.7M+1,881%
Total equity$567.0M+237%
Total assets$671.6M+157%

Cash flow

See full
Operating cash flow-$87.1M-8.4%
CapEx$164.0K+343%
Free cash flow-$87.2M-8.5%

Valuation

See full
Market cap$3.54B+686%
Enterprise value$3.52B+940%
P/S421.8×

Profitability

See full
Operating margin-5,364%
Net margin-2,825.7%
FCF margin-4,487.4%

Returns & leverage

See full
Return on equity-64.6%
Debt / equity0.1×+0.1×
Current ratio7.5×+3.8×

Where this comes from

Reported directly by Alumis Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The source filing: Alumis Inc.’s 10-Q, filed May 14, 2026.

Filed
May 14, 2026, 4:16 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001847367-26-000010
(in thousands, except share and per share amounts)Three Months Ended March 31, 2026Three Months Ended March 31, 2025
Operating expenses:
Research and development expenses, including related party expenses of $66 and $262 for the three months ended March 31, 2026 and 2025, respectively81,54096,622
General and administrative expenses18,61022,295
Total operating expenses100,150118,917
Loss from operations(98,409)(101,528)
Other income (expense):
Interest income5,3492,609
Other income (expenses), net7(44)

Item 1. Financial Statements (Unaudited)

FAQ

What is Alumis Inc.'s total operating expenses?
Alumis Inc. (ALMS) reported total operating expenses of $100.15M in Q1 2026.
How has Alumis Inc.'s total operating expenses changed year-over-year?
Alumis Inc.'s total operating expenses decreased by 15.8% year-over-year, from $118.92M to $100.15M.
What is the long-term trend for Alumis Inc.'s total operating expenses?
Over 2 years (2023 to 2025), Alumis Inc.'s total operating expenses has grown at a 73.8% compound annual growth rate (CAGR), from $158.17M to $477.85M.
What does total operating expenses mean?
The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.

Ask your AI about Alumis Inc.'s total operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude